• Press releaseLast July 2025, national COCEMFE submitted 14 reports to the Government requesting the extension of early retirement to new pathologies, the result of an analytical endeavor carried out alongside its Associative Movement.
  • The Technical Commission has issued a favorable final report for seven of the fourteen pathologies submitted by national COCEMFE: spina bifida, Parkinson's disease, myotonic dystrophy type 1 (Steinert's disease), Huntington's disease, systemic sclerosis, variant transthyretin amyloidosis, and chronic kidney disease (stage G5).
  • AMIFP calls for promptness in completing the process and will continue working to achieve the inclusion of the remaining pathologies supported by sufficient scientific evidence regarding reduced life expectancy, as stipulated in the procedure approved by the Government.

Download press release

(Madrid, January 28, 2026)

AMIFP, a private non-profit entity advocating for the rights of persons with disabilities linked to the National Police, welcomes the favorable final report issued by the Technical Commission for the inclusion of seven new pathologies in the early retirement procedure for workers with a degree of disability equal to or greater than 45%, within the framework established by Royal Decree 1851/2009.

This progress represents an achievement of tremendous social relevance, resulting from intensive policy advocacy, technical coordination, and the cohesion of national COCEMFE's Associative Movement, a confederation of which AMIFP is an affiliated member and which, over recent years, has championed the expansion of the pathologies eligible for this right by providing rigorous scientific evidence on the reduced life expectancy associated with certain conditions, as established by the procedure approved by the Government for this purpose.

The pathologies that have received a favorable final report are: spina bifida, Parkinson's disease, myotonic dystrophy type 1 (Steinert's disease), Huntington's disease, systemic sclerosis, variant transthyretin amyloidosis, and chronic kidney disease (stage G5).

“This report represents a decisive step toward a fairer retirement, tailored to the living and working realities of many persons with disabilities; a necessary recognition of rights and an example of how scientific evidence can and should guide public policy,” emphasized AMIFP.

For this Association, this step confirms that collaborative efforts among disability organizations, entities representing each pathology, and specialized scientific expertise constitute the appropriate pathway toward advancing the recognition of rights.

“This progress demonstrates that when the associative movement works in a coordinated manner, with rigor and technical backing, structural changes can be achieved that improve the lives of thousands of people,” stated the president of national COCEMFE, Anxo Queiruga.

Nevertheless, AMIFP underscores the need to proceed with prudence and clarity to avoid generating false expectations. The favorable final report does not yet entail the effective incorporation of these pathologies into the annex of Royal Decree 1851/2009, an essential prerequisite for individuals diagnosed with them to apply for early retirement.

As established by Order ISM/444/2025, the procedure outlines the issuance of the final report by the Technical Commission and, subsequently, the administrative resolution by the Directorate General for Social Security Regulation. In the event of a favorable resolution, it will be necessary to initiate the regulatory amendment of the Royal Decree's annex and its publication in the Official State Gazette, at which point the right may be effectively exercised.

In this context, AMIFP urges the Ministry of Inclusion, Social Security, and Migration to proceed with the utmost urgency to conclude the pending procedures, so that this progress translates as swiftly as possible into a real and effective right for affected individuals who meet the legal requirements.

“This is not an end point, but an intermediate milestone,” emphasized Queiruga. “At national COCEMFE, we will continue working to ensure that the pathologies not yet incorporated, along with others supported by sufficient scientific evidence regarding reduced life expectancy, may also gain access to early retirement. We are speaking of health, dignity, and equalizing the transition into retirement in the face of specific circumstances experienced by many persons with physical and organic disabilities, especially in contexts of career paths marked by precariousness, physical overexertion, or the progressive deterioration associated with particular pathologies.”

In this regard, national COCEMFE will continue collaborating with the organizations within its Associative Movement and expert technical personnel to further expand the list of included pathologies, both by submitting appeals against unfavorable reports and through the annual calls for the submission of extension proposals.